Charles River Laboratories criver.com


Charles River Laboratories (NYSE: CRL) provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe accelerate their research and drug development efforts. The company's dedicated employees are focused on helping clients improve and expedite the discovery, early-stage development, and safe manufacture of new therapies for the patients who need them.

Charles River Laboratories (NYSE: CRL) provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe accelerate their research and drug development...Show all

Company (IPO / Went public)

Phone: 877-274-8371

Fax:

251 Ballardvale Street

Wilmington, 1887
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Charles River Laboratories $133M Mar 7, 2001
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Charles River Laboratories Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Immunetrics

Pittsburgh, Pennsylvania, United States
Alive / ActiveNobody prototypes a jet plane or car without running the empirical data through a computer model. A clinical trial is also a prototype. Now, pharmaceutical companies can simulate as many scenarios as necessary to optimize success in the final design of their clinical trials.nBiosimulation technology from Immunetrics Inc. aims to provide a bridge from research and experiment to trial design. Immunetrics' toolset aims to provide predictive computer models based on biological mechanisms. The inputs...Show allLogin to see details

BioDelivery Sciences International

Raleigh, North Carolina, United States
IPO / Went publicBioDelivery Sciences (BDSI) is a specialty pharmaceutical company<br/><br/><br/><br/>that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.<br/><br/><br/><br/>The development strategy focuses on utilization of the FDA's 505(b)(2) approval process to potentially obtain timely and efficient app...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Optical method for detecting viable microorganisms in a cell sample May 02, 2013 Jul 18, 2017 Patent
Filtration system and use thereof Sep 18, 2015 Apr 18, 2017 Patent
Filtration device Nov 04, 2014 Mar 28, 2017 Patent
Adapter Nov 04, 2014 Jan 10, 2017 Patent
Base Nov 04, 2014 Jan 10, 2017 Patent
See all 36 patents